Azaquinazoline inhibitors of atypical protein kinase C
US9896446B2 · kind B2 · utility
2Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2015 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Jan 13, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6584
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides a compound of formula (I)or a salt thereof, wherein R7, R8, R9, G, and X are as defined herein. This application further describes compositions comprising the same. Compounds of formula (I) and their salts have aPKC inhibitory activity, and may be used to treat proliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.